---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-26-000040"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2026-08-13T20:17:02+00:00"
generated_at: "2026-08-13T20:19:26.361040+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# PetMed Express Q1 net sales down 19.9% to $41.0M; net loss narrows to $6.1M

## Summary
- Net sales $41.0M vs $51.2M prior year, down 19.9% on lower prescription sales and reduced promotional usage.
- Net loss $6.1M ($0.28/share) vs $34.2M ($1.65/share) loss prior year; improvement from no goodwill/trade name impairment.
- Adjusted EBITDA $(3.4)M vs $(2.7)M prior year.
- Acquired 70,000 new customers; cost per new customer down 15% YoY; G&A down ~14%.
- Completed SAP ERP rollout; sale-leaseback transaction to strengthen balance sheet.

## SEC filing metadata
- accession: 0001040130-26-000040
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2026-08-13T20:17:02+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/0001040130-26-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/pets-20260813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-26-000040
- JSON: https://secwatch.observer/filing/0001040130-26-000040.json
- Plain text: https://secwatch.observer/filing/0001040130-26-000040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.